2008

1. Aliskiren - The first of a new class of antihypertensive

   Drugs in Context, Vol. 4, Núm. 1, pp. 105-120

2. Cervarix - Preventing cervical cancer and other diseases related to HPV

   Drugs in Context, Vol. 4, Núm. 1, pp. 59-70

3. Coversyl Plus - Treating hypertension and improving clinical outcomes in T2D and other high risk groups

   Drugs in Context, Vol. 4, Núm. 1, pp. 71-84

4. Ezetimibe - A clinically effective and a cost-effective treatment option for dyslipidaemia

   Drugs in Context, Vol. 4, Núm. 1, pp. 85-104

5. Gardasil - Preventing cervical cancer and other diseases related to HPV

   Drugs in Context, Vol. 4, Núm. 1, pp. 29-40

6. Inegy - Effective combination treatment to target LDL-C levels

   Drugs in Context, Vol. 4, Núm. 1, pp. 41-58

7. Telmisartan - An effective antihypertensive for 24-hour blood pressure control

   Drugs in Context, Vol. 4, Núm. 1, pp. 1-14

8. Tiotropium - Advancing the treatment of COPD

   Drugs in Context, Vol. 4, Núm. 1, pp. 15-28